News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Dallas, Texas, May 25, 2023 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is pleased to announce that it has added serial technology entrepreneur and investor, Aaron Andrew, to its advisory board (the “Advisory Board”).
On January 5, 2023, the Company established the Advisory Board and approved and adopted a charter (the “Advisory Board Charter”) to govern the Advisory Board. Pursuant to the Advisory Board Charter, the primary function of the Advisory Board is to assist the Board of…
